|
Z.T. Astakhova, M.T. Zaseeva
Cardiotoxicity and chronic heart failure in the treatment of patients with gastric cancer: pathogenesis, methods of prevention and therapy
|
№7 / 2024
|
|
G.A. Ignatenko, A.E. Bagriy, A.V. Prikolota, O.A. Prikolota, E.S. Mikhailichenko, I.A. Golodnikov, O.N. Bagriy
Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation
|
№12 / 2023
|
|
O.N. Kurochkina, A.V. Baranov, A.S. Sazhina, A.N. Bogomolov
Modern methods of treatment of elderly patients with chronic heart failure: a literature review
|
№1-2 / 2023
|
|
D.A. Sychev, O.D. Ostroumova, A.P. Pereverzev, A.I. Kochetkov, M.V. Klepikova, E.Yu. Ebzeeva, V.A. De
Risk factors of drug-induced diseases. Part 2. Comorbid diseases and lifestyle factors
|
№12 / 2021
|
|
O.D. Ostroumova (1, 2), A.I. Kochetkov (1), S.V. Batyukina (1), N.L. Lyakhova (3)
Approaches to choosing a direct oral anticoagulant in the treatment of polymorbid patients with atrial fibrillation
|
№3 / 2020
|
|
V.A. Sergeeva (1), S.P. Eliseeva (2), E.V. Zhuravleva (1)
PERIPARTUM CARDIOMYOPATHY: 10-YEAR CLINICAL FOLLOW-UP
|
№6 / 2018
|
|
P.A. Lebedev (1), A.F. Verbovoy (1), K.A. Mateesku (1), M.Yu. Aleksandrov (2), R.A. Povalayeva (3)
LEFT VENTRICLE DYSFUNCTION AND ITS DETERMINANTS IN PATIENTS WITH ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION
|
№18 / 2017
|
|
M.E. Statsenko, S.V. Turkina, I.A. Tyshchenko, S.V. Fabritskaya, L.V. Poletaeva
POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY
|
№6 / 2017
|
|
M.Yu. Ogarkov (1), Yu. V. Kovaleva (1), T.A. Mulerova (2)
BISOPROLOL IN THE TREATMENT OF CHRONIC HEART FAILURE
|
№13 / 2016
|
|
S.A. Abduragimov (1), N.V. Teplovа (1), N.A. Volov (1), S.L. Sofrina (2), M.A. Benevskaya (1)
TAURINE IN THE COMPLEX TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION
|
№13 / 2016
|
|
A.S. Adamchik, D.I. Panchenko
INCREASED THYROID-STIMULATING HORMONE LEVEL AS A MARKER OF PROGRESSION OF HEART FAILURE IN CARDIAC PATIENTS
|
№5 / 2016
|
|
S.V. Shalaev (1, 2), L.V. Kremneva (3), O.V. Abaturova (1)
NEBIVOLOL IN THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE
|
№13 / 2015
|
Русский
